Indoco Remedies Limited (BOM:532612)
India · Delayed Price · Currency is INR 187.60
+1.60 (0.86%)
At close: Apr 2, 2026
Indoco Remedies Market Cap
Indoco Remedies has a market cap or net worth of 17.29 billion as of April 2, 2026. Its market cap has decreased by -16.42% in one year.
Market Cap
17.29B
Enterprise Value
27.03B
Revenue
17.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
187.60
Market Cap Chart
Since January 14, 2005, Indoco Remedies's market cap has increased from 4.66B to 17.29B, an increase of 270.95%. That is a compound annual growth rate of 6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 17.29B | -20.12% |
| Dec 31, 2025 | 21.64B | -29.33% |
| Dec 31, 2024 | 30.62B | -15.91% |
| Dec 29, 2023 | 36.42B | -2.82% |
| Dec 30, 2022 | 37.47B | -10.49% |
| Dec 31, 2021 | 41.86B | 49.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novartis India | 25.38B |
| Bliss GVS Pharma | 24.79B |
| Unichem Laboratories | 21.01B |
| Morepen Laboratories | 20.81B |
| Hikal | 19.81B |
| Kwality Pharmaceuticals | 14.78B |
| Amrutanjan Health Care | 14.72B |
| Shukra Pharmaceuticals | 13.96B |